Literature DB >> 30280762

Targeted inhibition of β-catenin by miR-320 and decreased MMP-13 expression in suppressing chondrocyte collagen degradation.

H-X Zhang1, C Sun, H-C Yu, B Song, Z-X Pan.   

Abstract

OBJECTIVE: Wnt/β-catenin pathway plays a critical role in modulating embryonic development, cell growth, and differentiation. The over-expression of β-catenin activates this pathway and up-regulates expression of matrix metalloproteinase-13 (MMP-13), and promotes matrix degradation and occurrence of osteoarthritis (OA). This study aims to explore the effect of miR-320 expression in OA chondrocyte and underlying mechanisms. PATIENTS AND METHODS: Chondrocyte tissues from OA patients and normal individuals were collected for the detection of expression levels of miR-320, β-catenin, MMP-13, and alpha-1 chain of type II collagen (COL2A1). Dual luciferase reporter assay was performed to test targeted regulation between miR-320 and β-catenin. IL-1β was used to simulate in vitro cultured chondrocytes, which were transfected with miR-320 mimic and/or si-β-catenin, followed by quantification of miR-320, β-catenin, MMP-13, and COL2A1.
RESULTS: In chondrocytes of OA patients, expression of microRNA (miR)-320 is decreased. Bioinformatics analysis revealed complementary binding sites between miR-320 and β-catenin. Compared to control group, increasing levels of β-catenin and MMP-13 expression with reduction of miR-320 and COL2A1 expressions were observed in OA chondrocytes. Transfection of miR-320 mimic and/or si-β-catenin depressed expression of β-catenin and MMP-13 inside chondrocytes, accompanied with elevation of COL2A1 expression.
CONCLUSIONS: MiR-320 expression in OA chondrocyte is decreased, accompanied with up regulation of β-catenin and MMP-13. MiR-320 can inhibit β-catenin and MMP-13 expressions, elevates COL2A1 expression, which provides novel insights for the treatment of osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30280762     DOI: 10.26355/eurrev_201809_15909

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Long non-coding XIST raises methylation of TIMP-3 promoter to regulate collagen degradation in osteoarthritic chondrocytes after tibial plateau fracture.

Authors:  Hongwei Chen; Shengdi Yang; Ruyi Shao
Journal:  Arthritis Res Ther       Date:  2019-12-09       Impact factor: 5.156

2.  MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis.

Authors:  Yiqun Li; Jing Huang; Chaojun Hu; Jiaxin Zhou; Dong Xu; Yong Hou; Chanyuan Wu; Jiuliang Zhao; Mengtao Li; Xiaofeng Zeng; Changzheng Liu; Qian Wang; Yan Zhao
Journal:  Arthritis Res Ther       Date:  2021-01-11       Impact factor: 5.156

3.  Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort.

Authors:  Shabana Amanda Ali; Osvaldo Espin-Garcia; Andy K Wong; Pratibha Potla; Chiara Pastrello; Madison McIntyre; Starlee Lively; Igor Jurisica; Rajiv Gandhi; Mohit Kapoor
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-18       Impact factor: 5.346

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.